Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL)

Typically moves ±7.51% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-11-13 ESTIMATED
search

Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) has reported earnings 21 times since May 17, 2021. The stock moves an average of ±7.51% the day after reporting, closing higher 61.9% of the time. Its largest post-earnings gain was +6.89% (May 10, 2023) and its largest decline was -30.15% (Nov 06, 2023). The next earnings report is predicted for 2026-11-13 (estimated).

Earnings reactions

How ZNTL moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

21

Avg Abs. Movement

±7.51%

Positive %

61.9%

Negative %

38.1%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 06, 2026 ☽ POST -15.73% open_in_new
May 12, 2026 ☽ POST +0.47% open_in_new
Mar 26, 2026 ☽ POST -21.64% open_in_new
Nov 10, 2025 ☽ POST +5.68% open_in_new
event

Earnings Count

21

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.51%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 20 →
20
Funds holding
$43704748
Total value held
Buying
14 added · 5 reduced
Blackrock, Inc.
$18204597 +195.59%
Bank Of America Corp /De/
$5406053 -1.56%
State Street Corp
$4303968 +255.41%
Pfizer Inc
$3853489 Held
Morgan Stanley
$2285563 +34.56%

Frequently asked about ZNTL earnings

When does Zentalis Pharmaceuticals, Inc. Common Stock report earnings next? expand_more

Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ZNTL stock move after earnings? expand_more

Over 21 reports, ZNTL has moved an average of ±7.51% the session after earnings, closing higher 61.9% of the time.

What was ZNTL's biggest post-earnings move? expand_more

ZNTL's largest post-earnings gain on record was +6.89% on May 10, 2023, and its largest decline was -30.15% on Nov 06, 2023.

Where can I find Zentalis Pharmaceuticals, Inc. Common Stock's SEC filings? expand_more

All of Zentalis Pharmaceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.